General Information of the Compound
| Compound ID |
CP0495701
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,5S,8R,13S)-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-13-(oxan-4-ylamino)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H44N6O5
|
||||||||||||||||||
| Molecular Weight |
664.807
|
||||||||||||||||||
| Canonical SMILES |
O=C1C[C@H](NC2CCOCC2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2ccccc2)CN1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H44N6O5/c45-35-22-34(41-28-15-17-49-18-16-28)38(48)44-33(21-27-23-39-31-14-8-7-13-30(27)31)37(47)43-32(20-26-11-5-2-6-12-26)36(46)42-29(24-40-35)19-25-9-3-1-4-10-25/h1-14,23,28-29,32-34,39,41H,15-22,24H2,(H,40,45)(H,42,46)(H,43,47)(H,44,48)/t29-,32+,33+,34+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VOQTXNSVZQBLKS-HOWKLTHKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound